Talk With Me Baby for Infant Language Development
(TWMB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Talk With Me Baby program encourages caregivers to engage more with their infants, thereby enhancing the child's language environment at home. Caregivers will receive the program during regular well-child checkups for young children. Participants will record conversations with their infants before and after the program to measure changes. Families with children aged two to nine months, who attend well-child checkups and can complete the study in English, may qualify for this trial. As an unphased trial, this study offers families a unique opportunity to contribute to research that could improve early childhood language development.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the trial focuses on language development and not on medication use.
What prior data suggests that the Talk With Me Baby program is safe for infant language development?
Research has shown that the Talk With Me Baby (TWMB) program aims to improve communication between caregivers and infants. As an educational program, TWMB presents no safety concerns. It is neither a medication nor a medical treatment, so it lacks the side effects or risks associated with drug trials.
The program encourages parents to engage more in conversations with their babies, which can aid brain development and learning. Since it involves simple activities like regular conversations with infants, it is generally safe for all participants.12345Why are researchers excited about this trial?
"Talk With Me Baby" is unique because it focuses on enhancing infant language development through verbal interaction, rather than relying on traditional interventions like speech therapy or educational programs aimed at older children. Most treatments for language development involve structured learning environments or professional intervention, but this approach empowers parents and caregivers to engage directly with their infants through everyday conversation. Researchers are excited about this method because it harnesses the natural bond between caregiver and child, potentially leading to more organic and impactful language development outcomes from a very early age.
What evidence suggests that the Talk With Me Baby program is effective for improving infant language development?
Research shows that the Talk With Me Baby (TWMB) program, which participants in this trial will experience, can enhance early language development in babies. Studies have found that babies who hear more directed speech, as encouraged by the TWMB program, better understand familiar words and have larger vocabularies by age two. Strong evidence indicates that the program is widely used and effective. Additionally, coaching for parents, similar to TWMB, has boosted language skills in babies. These findings suggest that the TWMB program could encourage caregivers to talk more to their babies, which is crucial for developing language skills.26789
Are You a Good Fit for This Trial?
This trial is for families with children aged 2-6 months who may be at risk of language development issues. Caregivers must commit to attending at least four well-child checkups and recording their conversations with their infant before and after receiving the TWMB program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Talk With Me Baby (TWMB) program during well-child checkups
Follow-up
Participants record their conversations with their infant before and after receiving the program
What Are the Treatments Tested in This Trial?
Interventions
- Talk With Me Baby
Find a Clinic Near You
Who Is Running the Clinical Trial?
IDeA States Pediatric Clinical Trials Network
Lead Sponsor
University of Kansas
Collaborator
National Institutes of Health (NIH)
Collaborator